Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
EBS compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
EBS
Emergent BioSolutions Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
EBS
Emergent BioSolutions Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
EBS
Emergent BioSolutions Inc.
Change
5.85
▼
−6.38%
Mkt cap
$321.3M
Revenue
$110M
Q3 FY26
Revenue
$743M
FY25
LLY
ELI Lilly & Co
Change
1,418.17
▲
+0.62%
Regular session
Nov 4 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 4 '26
EBS
Emergent BioSolutions Inc.
vs
LLY
ELI Lilly & Co
5.85
▼
−6.38%
Price
1,418.17
▲
+0.62%
$321.3M
Mkt cap
$1.3T
Q3 FY26
$110M
Revenue
$24.4B
Q3 FY26
FY25
$743M
Revenue
$65.2B
FY25
Change
Change
EBS
5.85
▼
−6.38%
vs
LLY
1,418.17
▲
+0.62%
Regular session
Nov 4 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
EBS, solid
LLY, dashed
Supply-chain overlap
Revenue flow
EBS: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only EBS
14
MGNX
Macrogenics
supplier
SABS
SAB Biotherapeutics
customer
—
Hikma Pharmaceuticals
unlisted
supplier
—
Barda
unlisted
customer
10 more · EBS chain
›
Shared
0
No shared counterparties.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
25 more · LLY chain
›